Equities

Comprehensive Healthcare Systems Inc

CHS:CVE

Comprehensive Healthcare Systems Inc

Actions
  • Price (CAD)0.005
  • Today's Change0.00 / 0.00%
  • Shares traded51.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jul 05 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Comprehensive Healthcare Systems Inc had revenues fall -10.90% from 4.30m to 3.84m, though the company grew net income from a loss of 5.11m to a smaller loss of 3.58m.
Gross margin32.91%
Net profit margin-46.31%
Operating margin-37.80%
Return on assets-137.35%
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Comprehensive Healthcare Systems Inc fell by 376.97k. Cash Flow from Financing totalled 852.45k or 22.22% of revenues. In addition the company used 1.23m for operations while cash used for investing totalled .
Cash flow per share-0.0109
Price/Cash flow per share--
Book value per share-0.0496
Tangible book value per share-0.0496
More ▼

Balance sheet in USDView more

Comprehensive Healthcare Systems Inc uses little or no debt in its capital structure.
Current ratio0.0447
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.